Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study to Evaluate the Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children

NCT01301313 is registered in ClinicalTrials.gov with Jose Luis Vazquez Martinez as lead sponsor.

NCT NCT01301313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01301313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study to Evaluate the Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children
Lead sponsor
Jose Luis Vazquez Martinez
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2011
Completion date
February 29, 2012
Enrollment
116 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure